journal article·2024-12

Advancing Recovery Post‐Spinal Cord Injury: Nanoparticle‐Mediated Reprogramming of Peripheral Macrophages

Jingsong Liu, Daqian Liu, Rui Ma, Zhengang Ma, Zhibin Peng, Yangyang Wang, Yishu Liu, Yubo Zhang, Pengfei Li, Mi Li, Zhiwei Luan, Yutong Zhao, Fangxing Xu, Yansong Wang

Advanced Functional Materials· Volume 34· Issue 51
Publisher page

Abstract

Abstract Spinal cord injuries (SCIs) often result in secondary damage; therefore, interventions beyond current cell transplantation methods must be explored. The innate phagocytic propensity of macrophages are exploited for artificially aged erythrocytes and developed a delivery system fusing erythrocytes with reactive oxygen species (ROS)‐reactive nanoparticles prepared from a diselenide‐bond cross‐linked organic compound. The system targets peripheral blood macrophages, delivering anti‐glutamate drug‐loaded nanoparticles to the SCI site, releasing the drug upon ROS stimulation. This efficiently enables targeted drug delivery and reprograms peripheral macrophages through synergistic action with erythrocytes and encapsulated nucleic acids, effectively modulating the immune microenvironment in the SCI zone (significantly reduces neuronal apoptosis and alters the macrophage phenotype in the SCI region). The approach effectively addresses glutamate toxicity and immune inflammation by effectively regulating the lesion microenvironment, providing protection to neurons and creating favorable conditions for regeneration. Departing from the conventional “red blood cell backpack” model, the “chocolate chip cookie” concept is paradigm‐altering, enabling multifaceted erythrocyte functions. Collectively, the system comprehensively enhances the post‐SCI microenvironment. Its efficacy in SCI treatment and innovative drug delivery approach open new possibilities for neural function recovery. By laying the groundwork for future clinical applications, the research pioneers a transformative path toward advancing SCI therapeutics.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immune cells in cancer · Spinal Cord Injury Research · Neonatal Respiratory Health Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedic Surgery The First Affiliated Hospital of Harbin Medical University Harbin Medical University Harbin 150000 P. R. China

The Key Laboratory of Myocardial Ischemia Ministry of Education Harbin Medical University Harbin 150000 P. R. China

NHC Key Laboratory of Cell Transplantation Harbin Medical University Harbin 150000 P. R. China

State Key Laboratory of Frigid Zone Cardiovascular Diseases Harbin Medical University Harbin China

The Second Affiliated Hospital of Harbin Medical University Harbin Medical University Harbin 150000 P. R. China

School of Pharmacy Yancheng Teachers University Yancheng 224051 P. R. China

Center for Endemic Disease Control Chinese Center for Disease Control and Prevention Harbin Medical University Harbin 150000 P. R. China

Key Lab of Etiology and Epidemiology Education Bureau of Heilongjiang Province & Ministry of Health (23618504) Harbin Medical University Harbin Heilongjiang 150000 P. R. China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Heilongjiang Province

References (55)

Show source-provided references
1. 10.2147/IJN.S39438910.2147/IJN.S394389 ↗
2. 10.1016/j.addr.2023.11482710.1016/j.addr.2023.114827 ↗
3. 10.1007/s00401-019-01992-310.1007/s00401-019-01992-3 ↗
4. 10.1007/s11064-017-2459-610.1007/s11064-017-2459-6 ↗
5. 10.1016/S0140-6736(02)07603-110.1016/S0140-6736(02)07603-1 ↗
6. 10.1016/j.neuroscience.2009.11.03310.1016/j.neuroscience.2009.11.033 ↗
7. 10.2147/IJN.S29815910.2147/IJN.S298159 ↗
8. 10.1172/JCI5964310.1172/JCI59643 ↗
9. 10.1093/brain/awab25010.1093/brain/awab250 ↗
10. 10.1016/j.bbi.2014.11.00710.1016/j.bbi.2014.11.007 ↗
11. 10.1146/annurev-pathmechdis-012418-01271810.1146/annurev-pathmechdis-012418-012718 ↗
12. 10.1002/JLB.6A1120-744R10.1002/JLB.6A1120-744R ↗
13. 10.1111/imm.1330010.1111/imm.13300 ↗
14. 10.1007/s10565-022-09748-810.1007/s10565-022-09748-8 ↗
15. 10.1016/j.intimp.2022.10877710.1016/j.intimp.2022.108777 ↗
16. 10.1038/nature0200610.1038/nature02006 ↗
17. 10.1161/CIRCRESAHA.119.31506910.1161/CIRCRESAHA.119.315069 ↗
18. 10.1038/s41392-023-01477-610.1038/s41392-023-01477-6 ↗
19. 10.1016/j.jconrel.2023.09.00110.1016/j.jconrel.2023.09.001 ↗
20. 10.1016/j.ajps.2017.11.00210.1016/j.ajps.2017.11.002 ↗
21. 10.1186/s40824-020-0184-810.1186/s40824-020-0184-8 ↗
22. 10.1002/adhm.20220131910.1002/adhm.202201319 ↗
23. 10.1021/jacs.9b1104610.1021/jacs.9b11046 ↗
24. 10.1016/j.biomaterials.2016.06.04410.1016/j.biomaterials.2016.06.044 ↗
25. 10.1016/j.celrep.2016.09.00810.1016/j.celrep.2016.09.008 ↗
26. 10.7150/thno.3651010.7150/thno.36510 ↗
27. 10.1016/j.bioactmat.2020.11.01410.1016/j.bioactmat.2020.11.014 ↗
28. 10.1016/j.bioactmat.2020.11.01410.1016/j.bioactmat.2020.11.014 ↗
29. 10.18632/oncotarget.946410.18632/oncotarget.9464 ↗
30. 10.1038/nature1132010.1038/nature11320 ↗
31. 10.1158/2326-6066.CIR-19-061610.1158/2326-6066.CIR-19-0616 ↗
32. 10.1073/pnas.090052710610.1073/pnas.0900527106 ↗
33. 10.1371/journal.ppat.100326110.1371/journal.ppat.1003261 ↗
34. 10.1038/s41578-021-00394-w10.1038/s41578-021-00394-w ↗
35. 10.1089/neu.2012.258710.1089/neu.2012.2587 ↗
36. 10.1157/1308328010.1157/13083280 ↗
37. 10.1016/S0168-8278(99)80115-910.1016/S0168-8278(99)80115-9 ↗
38. 10.1002/adma.20200205410.1002/adma.202002054 ↗
39. 10.1016/j.it.2020.07.00410.1016/j.it.2020.07.004 ↗
40. 10.1001/jamaneurol.2014.292710.1001/jamaneurol.2014.2927 ↗
41. 10.1016/j.pharmthera.2013.08.00110.1016/j.pharmthera.2013.08.001 ↗
42. 10.1186/s12974-014-0150-210.1186/s12974-014-0150-2 ↗
43. 10.1182/bloodadvances.201700467110.1182/bloodadvances.2017004671 ↗
44. 10.1002/adma.20230177910.1002/adma.202301779 ↗
45. 10.1016/j.immuni.2013.02.01210.1016/j.immuni.2013.02.012 ↗
46. 10.1002/jev2.1213710.1002/jev2.12137 ↗
47. 10.1002/smll.20210783810.1002/smll.202107838 ↗
48. 10.1016/j.actbio.2021.03.01810.1016/j.actbio.2021.03.018 ↗
49. 10.1016/j.ymthe.2019.09.00410.1016/j.ymthe.2019.09.004 ↗
50. 10.1111/cpr.1305010.1111/cpr.13050 ↗
51. 10.1016/j.bioactmat.2023.07.00310.1016/j.bioactmat.2023.07.003 ↗
52. 10.1016/j.biomaterials.2021.12127910.1016/j.biomaterials.2021.121279 ↗
53. 10.1002/adma.20230489610.1002/adma.202304896 ↗
54. 10.1016/j.addr.2014.11.00710.1016/j.addr.2014.11.007 ↗
55. J.Liu Reprogramming/engineering peripheral macrophages via cell relay‐delivery nanoparticles to promote functional recovery after spinal cord injury [Data set] Harvard Dataverse 2023 https://doi.org/10.7910/DVN/BPEG1L.